Taken together, our data suggest that the inhibition exerted by MSC on CXCR3 expression might cooperate with the other changes induced on het CD3+ cell surface to prevent intrathecal accumulation of T cells in MS. The gene discussed is CXCR3; the disease is myeloid sarcoma.